News

Article

Pharmaceutical Technology

Pharmaceutical Technology-07-02-2001
Volume25
Issue 7

The Role of USP in the Assessment of Microbiological Quality of Pharmaceuticals

USP ensures the microbiological quality of products by way of the development, proposal, and acceptance of general information chapters.

External Link - article-5413.pdf

Articles in this issue
Musings on the Past 25 Years
Reflections on Changes at FDA
Deliver the Dose
Middle-European Pharmaceutics in a Changing World
The BCS: Where Do We Go From Here?
The Role of USP in the Assessment of Microbiological Quality of Pharmaceuticals

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Related Content
Close up shot pharmacist holding nasal spray medicine at the drugstore.Seasonal health issues | Image Credit: © I Viewfinder - stock.adobe.com
September 16th 2025

FDA Approves Cortasis Nasal Spray, Enbumyst, for Edema

Patrick Lavery
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
September 16th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Image Credit: © Patrick Lavery - MJH Life Sciences
September 16th 2025

CPHI Frankfurt Expected to Draw More Than 60,000 Attendees in October

Patrick Lavery
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
September 16th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
Titanium dioxide, E171, dangerous additive concept. gum, pills, toothpaste, powder and sign with E171 on yellow background. copy space banner | Image credit: ©Анна Мартьянова - stock.adobe.com
September 16th 2025

The Impact of Europe’s Decision on the Use of Titanium Dioxide

Susan Haigney
Scientist Managing Prescription Drug Supply Chain | Image Credit: © leowolfert - stock.adobe.com
September 16th 2025

AI and Digital Oversight in Pharma Supply Chains: PDA Regulatory Conference Insights

Patrick Lavery
© 2025 MJH Life Sciences

All rights reserved.